Geode Capital Management, LLC Nex Immune, Inc. Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.2 - $0.3 $9,282 - $13,923	46,411 Added 75.18%	108,143 $22,000
Q1 2023 May 15, 2023	SELL	$0.3 - $0.6 $367 - $734	-1,224 Reduced 1.94%	61,732 $23,000
Q2 2022 Aug 12, 2022	SELL	$1.61 - $4.68 $197,812 - $575,008	-122,865 Reduced 66.12%	62,956 $101,000
Q1 2022 May 13, 2022	SELL	$1.79 - $4.65 $18,150 - $47,151	-10,140 Reduced 5.17%	185,821 $782,000
Q4 2021 Feb 11, 2022	SELL	$4.11 - $15.13 $67,691 - $249,191	-16,470 Reduced 7.75%	195,961 $903,000
Q3 2021 Nov 12, 2021	BUY	$10.32 - $16.9 $1.02 Million - $1.67 Million	99,095 Added 87.43%	212,431 $3.22 Million
Q2 2021 Aug 13, 2021	BUY	$14.98 - $23.89 $170,157 - $271,366	11,359 Added 11.14%	113,336 $1.85 Million
Q1 2021 May 12, 2021	BUY	$17.95 - $25.91 $1.83 Million - $2.64 Million	101,977 New	101,977 $1.95 Million

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $2.42M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.